Jean-Claude Chomel

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 8

Top Venues

Cancer

British journal of haematology

Leukemia & lymphoma

Leukemia

This page only lists publications with an associated author ORCID identifier.

Publications

Thomas Systchenko, Jean-Claude Chomel, Pilar Gallego-Hernanz, Niels Moya, Déborah Desmier, Natacha Maillard, Arthur Bobin, Mathilde Vonfeld, Hélène Gardeney, Emilie Cayssials, José Torregrosa
Combination of azacitidine, venetoclax and ruxolitinib in blast phase myeloproliferative neoplasms. British journal of haematology (2023)
Lara Boucher, Nathalie Sorel, Christophe Desterke, Mélanie Chollet, Laura Rozalska, Maria Pilar Gallego Hernanz, Emilie Cayssials, Anna Raimbault, Annelise Bennaceur-Griscelli, Ali G Turhan, Jean-Claude Chomel
Deciphering Potential Molecular Signatures to Differentiate Acute Myeloid Leukemia (AML) with BCR::ABL1 from Chronic Myeloid Leukemia (CML) in Blast Crisis. International journal of molecular sciences 24 (20) (2023)
Lydia Roy, Jean-Claude Chomel, Joëlle Guilhot, Agnès Guerci-Bresler, Martine Escoffre-Barbe, Stéphane Giraudier, Aude Charbonnier, Viviane Dubruille, Françoise Huguet, Hyacinthe Johnson-Ansah, Pascal Lenain, Shanti Ame, Gabriel Etienne, Franck Emmanuel Nicolini, Delphine Rea, Pascale Cony-Makhoul, Stéphane Courby, Jean-Christophe Ianotto, Laurence Legros, Antoine Machet, Valérie Coiteux, Eric Hermet, Emilie Cayssials, Stéphane Bouchet, Francois-Xavier Mahon, Philippe Rousselot, François Guilhot, null null
Dasatinib plus Peg-Interferon alpha 2b combination in newly diagnosed chronic phase chronic myeloid leukaemia: Results of a multicenter phase 2 study (DASA-PegIFN study). British journal of haematology (2022)
Francois Guilhot, Françoise Rigal-Huguet, Joëlle Guilhot, Agnès-Paule Guerci-Bresler, Frédéric Maloisel, Delphine Rea, Valérie Coiteux, Martine Gardembas, Christian Berthou, Anne Vekhoff, Eric Jourdan, Marc Berger, Loïc Fouillard, Magda Alexis, Laurence Legros, Philippe Rousselot, Alain Jacques Delmer, Pascal Lenain, Martine Escoffre Barbe, Emmanuel Gyan, Claude-Eric Bulabois, Viviane Dubruille, Bertrand Joly, Bertrand Pollet, Pascale Cony-Makhoul, Hyacinthe Johnson-Ansah, Melanie Mercier, Denis Caillot, Aude Charbonnier, Jean-Jacques Kiladjian, Jacques Chapiro, Amélie Penot, Véronique Dorvaux, Iona Vaida, Alberto Santagostino, Lydia Roy, Hacene Zerazhi, Erick Deconinck, Herve Maisonneuve, Isabelle Plantier, Delphine Lebon, Yazid Arkam, Nathalie Cambier, Kamel Ghomari, Jean-Michel Miclea, Sylvie Glaisner, Jean-Michel Cayuela, Jean-Claude Chomel, Marc Muller, Ludovic Lhermitte, Marc Delord, Claude Preudhomme, Gabriel Etienne, François-Xavier Mahon, Franck-Emmanuel Nicolini, null null
Long-term outcome of imatinib 400 mg compared to imatinib 600 mg or imatinib 400 mg daily in combination with cytarabine or pegylated interferon alpha 2a for chronic myeloid leukaemia: results from the French SPIRIT phase III randomised trial. Leukemia 35 (8) (2021)
Nathalie Sorel, Anna Raimbault, Françoise Brizard, Thibault Depaire, Valentina Pierini, Christelle Dupraz, Frédéric Millot, Cristina Mecucci, Jean-Claude Chomel
Identification and genetic characterization of a NUP98-HHEX molecular rearrangement in a pediatric acute myeloid leukemia. Leukemia & lymphoma (2021)
Emilie Cayssials, Jose Torregrosa-Diaz, Pilar Gallego-Hernanz, Florence Tartarin, Thomas Systchenko, Natacha Maillard, Déborah Desmier, Antoine Machet, Emmanuel Fleck, Anne Corby, Carine Motard, Guillaume Denis, André Herbelin, Jean-Marc Gombert, Lydia Roy, Stéphanie Ragot, Xavier Leleu, François Guilhot, Jean-Claude Chomel
Low-dose tyrosine kinase inhibitors before treatment discontinuation do not impair treatment-free remission in chronic myeloid leukemia patients: Results of a retrospective study. Cancer 126 (15) (2020)
Emilie Cayssials, Jose Torregrosa-Diaz, Xavier Leleu, François Guilhot, Jean-Claude Chomel
Reply to Comment on low-dose tyrosine kinase inhibitors before treatment discontinuation do not impair treatment-free remission in chronic myeloid leukemia patients: Results of a retrospective study. Cancer 127 (6) (2020)
Maria Pilar Gallego Hernanz, José Miguel Torregrosa Diaz, Nathalie Sorel, Arthur Bobin, Elodie Dindinaud, Sabrina Bouyer, Deborah Desmier, Françoise Brizard, Xavier Leleu, Natacha Maillard, Jean-Claude Chomel
Long-term molecular remission in a patient with acute myeloid leukemia harboring a new NUP98-LEDGF rearrangement. Cancer medicine 8 (4) (2019)

Jean-Claude Chomel.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jean-Claude Chomel